Answers are grounded in this paper and cite their sources.
Recombination signal binding protein for immunoglobulin κ J region (RBPJ) and RBPJ‑like protein (RBPJL) are members of the transcription factor family Suppressor of Hairless [Su(H)] and central components of Notch signaling. Aberrant Notch signaling is consistently involved in pancreatic inflammation and carcinogenesis. Importantly, RBPJ is the primary DNA‑binding transcription factor in the canonical Notch signaling pathway. RBPJL is a pancreas‑specific homolog that acts as a Notch signaling inhibitor and can promote terminal acinar cell differentiation. Functional differences set them apart from conventional Notch pathway components and underlie their involvement in diverse physiological and pathological processes. In a Notch‑independent manner, RBPJ and RBPJL can both form a complex with pancreas transcription factor 1A (PTF1A). During pancreatic development, the progressive replacement of RBPJ by RBPJL in the PTF1A complex marks the transition from progenitor maintenance to mature acinar identity. In disease, RBPJL is frequently downregulated or silenced in pancreatitis and pancreatic ductal adenocarcinoma, while RBPJ persists or becomes dysregulated, contributing to inflammation, fibrosis and neoplastic progression. This review summarizes the structural and functional divergence of this antagonistic pair, their context‑dependent roles in pancreatic development, inflammation and carcinogenesis and emerging therapeutic strategies targeting the RBPJ/RBPJL axis.
No takes yet. Share an insight, caveat, or question.
Pan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: